In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2Y
Open Access
- 1 January 2021
- journal article
- editorial
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 6 (1), e000765
- https://doi.org/10.1136/bmjophth-2021-000765
Abstract
No abstract availableFunding Information
- Public Health Agency of Canada
This publication has 10 references indexed in Scilit:
- Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19Ophthalmology, 2021
- Prevalence of SARS-CoV-2 in human post-mortem ocular tissuesThe Ocular Surface, 2021
- Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemicAmerican Journal of Otolaryngology, 2020
- Virucidal benefits of povidone-iodine use on the ocular surface: a reviewBMJ Open Ophthalmology, 2020
- Assessing the Contributions of Inactivation, Removal, and Transfer of Ebola Virus and Vesicular Stomatitis Virus by Disinfectant Pre-soaked WipesFrontiers in Public Health, 2020
- Lack of Rule-Adherence During Mountain Gorilla Tourism Encounters in Bwindi Impenetrable National Park, Uganda, Places Gorillas at Risk From Human DiseaseFrontiers in Public Health, 2020
- Effectiveness of Dettol Antiseptic Liquid for Inactivation of Ebola Virus in SuspensionScientific Reports, 2019
- Asymmetric paralog evolution between the “cryptic” gene Bmp16 and its well-studied sister genes Bmp2 and Bmp4Scientific Reports, 2019
- Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particlesScientific Reports, 2019
- Automated minimization of steric clashes in protein structuresProteins, 2010